H. Lundbeck A/S operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other
pharmaceutical manufacturers in Europe:
Jazz Pharmaceuticals Plc
sales of 1.93 billion Euros [US$2.27 billion]
of which 76%
Stada Arzneimittel AG
(2.61 billion Euros [US$3.06 billion]
of which 59%
was Generics), and
Hikma Pharmaceuticals PLC
based in UNITED KINGDOM
(£1.72 billion [US$2.25 billion]
of which 41%
was Injectable Pharmaceuticals).
H. Lundbeck A/S reported sales of 17.04 billion Danish Kroner (US$2.69 billion)
December of 2019.
decrease of 6.0%
versus 2018, when the company's sales were 18.12 billion Danish Kroner.